A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Candid Closes $63 Million Series B

Direct-to-consumer oral healthcare company to open 50 retail locations in 2019.

Candid , a direct-to-consumer brand expanding access and affordability to oral health care, announced it raised a $63.4M Series B financing round. Participating in the round were Candid’s Seed and Series A investors, including Greycroft, Bessemer, and e.ventures, and featured participation from new investors, including RiverPark Funds, blisce/, Redesign Health’s limited partners, and Mousse Partners. This brings Candid’s total funding to nearly $90 million.

The Series B round will fuel Candid’s rapid growth through both its retail and at-home channels, as well as provide capital to double the number of employees to 550 by the end of the year. Candid will be opening an additional 50 Candid Studios across the United States — bringing the total number of retail locations to more than 60 — offering an unparalleled in-person experience to those who seek it while continuing to offer remote treatment for patients in harder-to-access areas of the country. In just 18 months of operation, Candid has already opened 13 studios in major cities across the U.S. and served tens of thousands of customers.

Candid also announced it is donating $25 from every set of aligners it sells to Smile Train , a charity that supports free cleft surgery and comprehensive cleft care for children around the world. This partnership will result in at least 1,000 more cleft surgeries for children in 2019.

For more information or to view Candid’s studio locations visit Candidco.com

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.